Dan Li is currently the Vice President of Business Development and Portfolio Management at CANbridge Pharmaceuticals Inc., a global biotech start-up focused on accelerating the development and commercialization of innovative drugs in rare disease and oncology. Prior to joining CANbridge, Dan Li served as the Business Development Lead for Strategy and Business Development at Pfizer. Dan has a Bachelor's degree in Biological Sciences from Peking University and a Master's degree in Applied Biotechnology from Uppsala University.
Org chart
Sign up to view 1 direct report
Get started
